Atlas Trials

Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues

Clinical trial NCT04822688 · COMPLETED

Trial details

NCT number
NCT04822688
Sponsor
Thomas Jefferson University
Status
COMPLETED
Study type
OBSERVATIONAL
GlioblastomaMalignant Solid Neoplasm
Start date
2021-02-03
Primary completion
2025-06-30
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.